SIMILAR PATTERNS OF AMINO ACIDS FOR 3PHA_C_ACRC701
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1k8g | TELOMERE-BINDINGPROTEIN ALPHASUBUNIT (Sterkiella nova) |
PF02765(POT1) | 5 | ILE A 78ASP A 223ASP A 225ARG A 272ASP A 60 | None | 1.40A | 3phaC-1k8gA:undetectable | 3phaC-1k8gA:18.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ph5 | TELOMERE-BINDINGPROTEIN ALPHASUBUNIT (Sterkiella nova) |
PF02765(POT1) | 5 | ILE A 78ASP A 223ASP A 225ARG A 272ASP A 60 | None | 1.44A | 3phaC-1ph5A:undetectable | 3phaC-1ph5A:20.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1sp3 | CYTOCHROME C,PUTATIVE (Shewanellaoneidensis) |
PF11783(Cytochrome_cB)PF13435(Cytochrome_C554) | 5 | ASP A 205ASP A 156ILE A 237ARG A 397HIS A 154 | HEM A 805 (-3.8A)NoneNoneHEM A 805 ( 3.9A)HEM A 802 (-4.1A) | 1.48A | 3phaC-1sp3A:undetectable | 3phaC-1sp3A:20.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2cb4 | MOSQUITOCIDAL TOXIN (Lysinibacillussphaericus) |
no annotation | 5 | ASP A 273ILE A 139ASP A 105ASP A 99ARG A 97 | None | 1.02A | 3phaC-2cb4A:undetectable | 3phaC-2cb4A:17.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 10 | ASP A 87ASP A 212ILE A 213TRP A 284ASP A 320ARG A 400TRP A 413ASP A 416PHE A 449HIS A 480 | BOG A2000 (-2.7A)NoneNoneNoneNoneBOG A2000 (-3.1A)NoneBOG A2000 (-3.0A)NoneNone | 0.52A | 3phaC-2g3nA:41.5 | 3phaC-2g3nA:27.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 6 | ASP A 87ASP A 212ILE A 249ARG A 400ASP A 416PHE A 449 | BOG A2000 (-2.7A)NoneNoneBOG A2000 (-3.1A)BOG A2000 (-3.0A)None | 1.38A | 3phaC-2g3nA:41.5 | 3phaC-2g3nA:27.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vsa | MOSQUITOCIDAL TOXIN (Lysinibacillussphaericus) |
PF05588(Botulinum_HA-17)PF14200(RicinB_lectin_2) | 5 | ASP A 273ILE A 139ASP A 105ASP A 99ARG A 97 | None | 0.99A | 3phaC-2vsaA:undetectable | 3phaC-2vsaA:20.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2x2i | ALPHA-1,4-GLUCANLYASE ISOZYME 1 (Gracilariopsislemaneiformis) |
PF01055(Glyco_hydro_31) | 8 | ASP A 239ASP A 412ASP A 553ARG A 649TRP A 662ASP A 665PHE A 698HIS A 731 | QPS A1050 (-2.5A)QPS A1050 (-3.2A)QPS A1050 (-3.1A)QPS A1050 (-3.2A)QPS A1050 (-4.6A)QPS A1050 (-2.7A)QPS A1050 (-4.3A)QPS A1050 (-4.3A) | 0.47A | 3phaC-2x2iA:35.0 | 3phaC-2x2iA:24.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xvg | ALPHA XYLOSIDASE (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 7 | ASP A 470ASP A 582ARG A 642TRP A 656ASP A 659PHE A 692HIS A 740 | None | 0.46A | 3phaC-2xvgA:38.2 | 3phaC-2xvgA:23.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xvg | ALPHA XYLOSIDASE (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 5 | ASP A 470TRP A 511ASP A 659PHE A 692HIS A 740 | None | 1.00A | 3phaC-2xvgA:38.2 | 3phaC-2xvgA:23.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ctt | MALTASE-GLUCOAMYLASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 10 | ASP A 203ASP A 327ILE A 328TRP A 406ASP A 443ARG A 526TRP A 539ASP A 542PHE A 575HIS A 600 | GOL A3001 (-2.6A)3CU A1001 (-2.7A)3CU A1001 ( 3.9A)None3CU A1001 (-2.7A)3CU A1001 ( 3.5A)3CU A1001 (-4.6A)3CU A1001 ( 2.5A)3CU A1001 (-4.5A)3CU A1001 (-3.9A) | 0.43A | 3phaC-3cttA:40.8 | 3phaC-3cttA:25.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ctt | MALTASE-GLUCOAMYLASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 6 | ASP A 203ASP A 327ILE A 364ARG A 526ASP A 542PHE A 575 | GOL A3001 (-2.6A)3CU A1001 (-2.7A)3CU A1001 (-4.5A)3CU A1001 ( 3.5A)3CU A1001 ( 2.5A)3CU A1001 (-4.5A) | 1.39A | 3phaC-3cttA:40.8 | 3phaC-3cttA:25.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lm3 | UNCHARACTERIZEDPROTEIN (Parabacteroidesdistasonis) |
PF12979(DUF3863)PF12980(DUF3864) | 5 | ILE A 201ASP A 452ASP A 414ARG A 396ASP A 213 | None | 1.31A | 3phaC-3lm3A:2.6 | 3phaC-3lm3A:22.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lpp | SUCRASE-ISOMALTASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 10 | ASP A 231ASP A 355ILE A 356TRP A 435ASP A 472ARG A 555TRP A 568ASP A 571PHE A 604HIS A 629 | NoneTRS A6001 (-2.9A)TRS A6001 ( 4.0A)TRS A6001 ( 4.6A)TRS A6001 (-3.2A)TRS A6001 ( 4.6A)NoneTRS A6001 ( 3.7A)TRS A6001 (-4.4A)TRS A6001 (-4.2A) | 0.38A | 3phaC-3lppA:36.1 | 3phaC-3lppA:24.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lpp | SUCRASE-ISOMALTASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 6 | ASP A 231ASP A 355ILE A 392ARG A 555ASP A 571PHE A 604 | NoneTRS A6001 (-2.9A)NoneTRS A6001 ( 4.6A)TRS A6001 ( 3.7A)TRS A6001 (-4.4A) | 1.39A | 3phaC-3lppA:36.1 | 3phaC-3lppA:24.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nua | PHOSPHORIBOSYLAMINOIMIDAZOLE-SUCCINOCARBOXAMIDE SYNTHASE (Clostridiumperfringens) |
PF01259(SAICAR_synt) | 5 | ASP A 176ILE A 175TRP A 202ASP A 213ARG A 217 | AMP A 242 (-3.4A)NoneNoneNoneNone | 1.40A | 3phaC-3nuaA:undetectable | 3phaC-3nuaA:17.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3poc | ALPHA-GLUCOSIDASE (Blautia obeum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 11 | ASP A 73ILE A 76ASP A 197ILE A 198TRP A 271ARG A 404TRP A 417ASP A 420LYS A 422PHE A 453HIS A 478 | NoneNoneACR A 664 (-2.9A)ACR A 664 (-3.5A)ACR A 664 (-4.6A)ACR A 664 (-4.0A)ACR A 664 (-4.6A)ACR A 664 (-2.8A)NoneACR A 664 (-4.4A)ACR A 664 (-4.2A) | 0.38A | 3phaC-3pocA:73.6 | 3phaC-3pocA:99.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3poc | ALPHA-GLUCOSIDASE (Blautia obeum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 8 | ASP A 73ILE A 76ASP A 197ILE A 234ARG A 404ASP A 420LYS A 422PHE A 453 | NoneNoneACR A 664 (-2.9A)NoneACR A 664 (-4.0A)ACR A 664 (-2.8A)NoneACR A 664 (-4.4A) | 1.45A | 3phaC-3pocA:73.6 | 3phaC-3pocA:99.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3top | MALTASE-GLUCOAMYLASE, INTESTINAL (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 10 | ASP A1157ASP A1279ILE A1280TRP A1355ASP A1420ARG A1510TRP A1523ASP A1526PHE A1559HIS A1584 | ACR A 1 (-2.6A)ACR A 1 (-3.2A)ACR A 1 (-4.1A)ACR A 1 (-4.4A)ACR A 1 (-3.6A)ACR A 1 (-2.9A)ACR A 1 (-4.5A)ACR A 1 (-2.8A)ACR A 1 (-4.3A)ACR A 1 (-3.9A) | 0.42A | 3phaC-3topA:38.3 | 3phaC-3topA:24.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3top | MALTASE-GLUCOAMYLASE, INTESTINAL (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 6 | ASP A1157ASP A1279ILE A1315ARG A1510ASP A1526PHE A1559 | ACR A 1 (-2.6A)ACR A 1 (-3.2A)NoneACR A 1 (-2.9A)ACR A 1 (-2.8A)ACR A 1 (-4.3A) | 1.49A | 3phaC-3topA:38.3 | 3phaC-3topA:24.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wel | ALPHA-GLUCOSIDASE (Beta vulgaris) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16863(NtCtMGAM_N) | 10 | ASP A 232ASP A 357ILE A 358TRP A 432ASP A 469ARG A 552TRP A 565ASP A 568PHE A 601HIS A 626 | ACR A1001 (-2.7A)ACR A1001 (-3.0A)ACR A1001 (-3.6A)ACR A1001 ( 4.6A)ACR A1001 (-3.2A)ACR A1001 (-3.0A)ACR A1001 (-4.8A)ACR A1001 (-2.7A)ACR A1001 (-4.3A)ACR A1001 (-4.1A) | 0.35A | 3phaC-3welA:36.0 | 3phaC-3welA:26.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wel | ALPHA-GLUCOSIDASE (Beta vulgaris) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16863(NtCtMGAM_N) | 6 | ASP A 232ASP A 357ILE A 396ARG A 552ASP A 568PHE A 601 | ACR A1001 (-2.7A)ACR A1001 (-3.0A)ACR A1001 (-4.9A)ACR A1001 (-3.0A)ACR A1001 (-2.7A)ACR A1001 (-4.3A) | 1.36A | 3phaC-3welA:36.0 | 3phaC-3welA:26.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b9y | ALPHA-GLUCOSIDASE,PUTATIVE, ADG31B (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16338(DUF4968)PF17137(DUF5110) | 7 | ASP A 299ASP A 412ARG A 463TRP A 477ASP A 480PHE A 513HIS A 540 | None | 0.45A | 3phaC-4b9yA:34.2 | 3phaC-4b9yA:24.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b9y | ALPHA-GLUCOSIDASE,PUTATIVE, ADG31B (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16338(DUF4968)PF17137(DUF5110) | 6 | ASP A 299ILE A 341ARG A 463ASP A 480PHE A 513HIS A 540 | None | 1.36A | 3phaC-4b9yA:34.2 | 3phaC-4b9yA:24.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fe2 | PHOSPHORIBOSYLAMINOIMIDAZOLE-SUCCINOCARBOXAMIDE SYNTHASE (Streptococcuspneumoniae) |
PF01259(SAICAR_synt) | 5 | ASP A 174ILE A 173TRP A 201ASP A 211ARG A 215 | AIR A 301 (-2.9A)NoneNoneNoneNone | 1.46A | 3phaC-4fe2A:undetectable | 3phaC-4fe2A:17.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4oua | LATENT FORM OF PPO4TYROSINASE (Agaricusbisporus) |
PF00264(Tyrosinase) | 5 | ASP B 133ILE B 254ILE B 370ASP B 354ARG B 288 | None | 1.42A | 3phaC-4ouaB:undetectable | 3phaC-4ouaB:22.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4oua | PROTEOLYTICALLYACTIVATED FORM OFPPO4 TYROSINASE (Agaricusbisporus) |
PF00264(Tyrosinase) | 5 | ASP A 133ILE A 254ILE A 370ASP A 354ARG A 288 | None | 1.35A | 3phaC-4ouaA:undetectable | 3phaC-4ouaA:20.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rxu | PERIPLASMICSUGAR-BINDINGPROTEIN (Chloroflexusaurantiacus) |
PF13407(Peripla_BP_4) | 5 | ASP A 138ILE A 111ASP A 298ARG A 64ASP A 68 | BGC A 402 (-3.0A)NoneBGC A 402 (-2.7A)BGC A 402 (-3.9A)None | 1.43A | 3phaC-4rxuA:2.1 | 3phaC-4rxuA:19.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4s2t | PROTEIN APP-1 (Caenorhabditiselegans) |
PF00557(Peptidase_M24)PF01321(Creatinase_N)PF16188(Peptidase_M24_C)PF16189(Creatinase_N_2) | 5 | ILE P 218ASP P 122ASP P 154ARG P 160ASP P 48 | None | 1.38A | 3phaC-4s2tP:undetectable | 3phaC-4s2tP:23.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5djw | ALPHA-GLUCOSIDASE II (Bacteroidesthetaiotaomicron) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 6 | ASP A 211TRP A 285ASP A 321ARG A 385ASP A 401PHE A 434 | None | 1.38A | 3phaC-5djwA:41.4 | 3phaC-5djwA:27.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dkx | ALPHAGLUCOSIDASE-LIKEPROTEIN (Chaetomiumthermophilum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 10 | ASP A 303ASP A 443ILE A 444TRP A 517ASP A 556ARG A 617TRP A 630ASP A 633PHE A 666HIS A 691 | NoneTRS A1001 (-2.9A)TRS A1001 ( 4.1A)TRS A1001 ( 4.9A)TRS A1001 (-3.2A)TRS A1001 (-4.0A)NoneTRS A1001 (-2.8A)TRS A1001 (-4.5A)TRS A1001 (-4.0A) | 0.37A | 3phaC-5dkxA:32.7 | 3phaC-5dkxA:23.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dkx | ALPHAGLUCOSIDASE-LIKEPROTEIN (Chaetomiumthermophilum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 7 | ASP A 303ASP A 443ILE A 480ARG A 617ASP A 633PHE A 666HIS A 691 | NoneTRS A1001 (-2.9A)NoneTRS A1001 (-4.0A)TRS A1001 (-2.8A)TRS A1001 (-4.5A)TRS A1001 (-4.0A) | 1.26A | 3phaC-5dkxA:32.7 | 3phaC-5dkxA:23.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7c | ALPHA-GLUCOSIDASE (Bacteroidesthetaiotaomicron) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 8 | ASP A 228ASP A 348ASP A 460ARG A 507TRP A 520ASP A 523PHE A 556HIS A 588 | None | 0.42A | 3phaC-5f7cA:34.3 | 3phaC-5f7cA:23.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7s | GLYCOSIDE HYDROLASEFAMILY 31 (Trueperellapyogenes) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 6 | ASP A 467ARG A 516TRP A 529ASP A 532PHE A 565HIS A 591 | CA A 805 (-2.9A) CA A 805 ( 4.6A)None CA A 805 ( 4.6A)NoneNone | 0.52A | 3phaC-5f7sA:34.6 | 3phaC-5f7sA:23.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7u | CYCLOALTERNAN-FORMING ENZYME (Listeriamonocytogenes) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16338(DUF4968)PF16990(CBM_35) | 5 | ARG A 614TRP A 627ASP A 630PHE A 663HIS A 689 | GLC A1116 (-2.8A)GLC A1117 (-4.6A)GLC A1117 (-2.7A)GLC A1116 (-4.6A)GLC A1117 (-4.1A) | 0.62A | 3phaC-5f7uA:32.1 | 3phaC-5f7uA:20.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 10 | ASP A 305ASP A 451ILE A 452TRP A 525ASP A 564ARG A 624TRP A 637ASP A 640PHE A 673HIS A 698 | None5GF A1021 (-2.0A)5GF A1021 (-3.6A)5GF A1021 (-3.7A)5GF A1021 (-2.1A)5GF A1021 (-3.4A)5GF A1021 ( 4.6A)5GF A1021 (-2.6A)5GF A1021 (-3.6A)5GF A1021 (-4.0A) | 0.41A | 3phaC-5hjrA:41.2 | 3phaC-5hjrA:25.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 8 | ASP A 305ASP A 451ILE A 488ARG A 624TRP A 637ASP A 640PHE A 673HIS A 698 | None5GF A1021 (-2.0A)None5GF A1021 (-3.4A)5GF A1021 ( 4.6A)5GF A1021 (-2.6A)5GF A1021 (-3.6A)5GF A1021 (-4.0A) | 1.18A | 3phaC-5hjrA:41.2 | 3phaC-5hjrA:25.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 5 | ASP A 640ASP A 305ARG A 624ASP A 564HIS A 492 | 5GF A1021 (-2.6A)None5GF A1021 (-3.4A)5GF A1021 (-2.1A)None | 1.50A | 3phaC-5hjrA:41.2 | 3phaC-5hjrA:25.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5iw7 | RIBOSOME BIOGENESISPROTEINTSR1,RIBOSOMEBIOGENESIS PROTEINTSR1 (Saccharomycescerevisiae) |
PF04950(RIBIOP_C)PF08142(AARP2CN) | 5 | ASP A 150ILE A 295ARG A 622TRP A 785ASP A 297 | None | 1.42A | 3phaC-5iw7A:undetectable | 3phaC-5iw7A:22.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jou | ALPHA-XYLOSIDASEBOGH31A (Bacteroidesovatus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 7 | ASP A 441ASP A 553ARG A 613TRP A 627ASP A 630PHE A 663HIS A 709 | EDO A1008 (-2.8A)EDO A1008 (-2.7A)EDO A1008 (-4.6A)NoneEDO A1008 (-3.0A)EDO A1008 (-4.3A)EDO A1008 (-4.0A) | 0.37A | 3phaC-5jouA:37.0 | 3phaC-5jouA:23.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jou | ALPHA-XYLOSIDASEBOGH31A (Bacteroidesovatus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 5 | ASP A 441TRP A 482ASP A 630PHE A 663HIS A 709 | EDO A1008 (-2.8A)NoneEDO A1008 (-3.0A)EDO A1008 (-4.3A)EDO A1008 (-4.0A) | 1.05A | 3phaC-5jouA:37.0 | 3phaC-5jouA:23.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kbp | GLYCOSYL HYDROLASE,FAMILY 38 (Enterococcusfaecalis) |
PF01074(Glyco_hydro_38)PF07748(Glyco_hydro_38C)PF09261(Alpha-mann_mid) | 5 | ILE A 570TRP A 190ASP A 231PHE A 127HIS A 350 | None | 1.45A | 3phaC-5kbpA:3.3 | 3phaC-5kbpA:20.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nn8 | LYSOSOMALALPHA-GLUCOSIDASE (Homo sapiens) |
no annotation | 6 | ASP A 282ASP A 404ILE A 441ARG A 600ASP A 616PHE A 649 | ACR A1015 (-2.6A)ACR A1015 (-3.0A)ACR A1015 (-4.3A)ACR A1015 (-3.1A)ACR A1015 (-2.7A)ACR A1015 (-4.3A) | 1.34A | 3phaC-5nn8A:42.8 | 3phaC-5nn8A:24.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nn8 | LYSOSOMALALPHA-GLUCOSIDASE (Homo sapiens) |
no annotation | 9 | ASP A 282ASP A 404TRP A 481ASP A 518ARG A 600TRP A 613ASP A 616PHE A 649HIS A 674 | ACR A1015 (-2.6A)ACR A1015 (-3.0A)ACR A1015 ( 4.6A)ACR A1015 (-3.1A)ACR A1015 (-3.1A)ACR A1015 (-4.8A)ACR A1015 (-2.7A)ACR A1015 (-4.3A)ACR A1015 (-4.0A) | 0.35A | 3phaC-5nn8A:42.8 | 3phaC-5nn8A:24.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x3j | GLYCOSIDE HYDROLASEFAMILY 31 (Kribbellaflavida) |
no annotation | 5 | ARG A 500TRP A 513ASP A 516PHE A 549HIS A 575 | GLC A 819 ( 2.9A)GLC A 822 ( 4.6A)GLC A 822 ( 2.8A)GLC A 822 ( 4.8A)GLC A 822 ( 4.0A) | 0.55A | 3phaC-5x3jA:30.3 | 3phaC-5x3jA:8.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x7s | GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE (Paenibacillussp. 598K) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF16990(CBM_35)PF17137(DUF5110) | 6 | ASP A 429ARG A 474TRP A 488ASP A 491PHE A 533HIS A 565 | None | 0.41A | 3phaC-5x7sA:21.6 | 3phaC-5x7sA:19.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6dch | SCOE PROTEIN (Streptomycescoeruleorubidus) |
no annotation | 5 | ILE A 65ASP A 140ILE A 323ASP A 315HIS A 314 | None | 1.22A | 3phaC-6dchA:undetectable | 3phaC-6dchA:8.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6dus | TYPE III SECRETIONSYSTEM EFFECTORPROTEIN (Salmonellaenterica) |
no annotation | 5 | ASP A 191ILE A 289ASP A 325ARG A 194HIS A 247 | NAG A 502 (-2.9A)None MG A 503 ( 2.9A)NAG A 502 ( 4.5A)None | 1.32A | 3phaC-6dusA:undetectable | 3phaC-6dusA:undetectable |